INTERSURGICAL - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 110,579,714 | 119,310,742 | 137,942,144 | 129,231,447 | 148,622,019 | 162,610,476 | 178,938,149 | 189,851,941 |
| Profit before tax | 3,823,136 | 1,481,293 | 12,374,361 | 2,216,060 | 7,779,325 | 2,082,324 | -1,438,772 | 12,555,329 |
| Net profit | 3,833,799 | 1,545,930 | 12,961,120 | 1,737,213 | 7,810,815 | 2,092,285 | -1,305,384 | 12,545,158 |
| Equity | 55,657,210 | 57,203,140 | 70,164,260 | 71,901,473 | 79,712,288 | 81,804,573 | 80,499,189 | 93,044,347 |
| Liabilities | 43,664,810 | 67,323,269 | 95,753,808 | 126,383,626 | 135,385,374 | 130,972,585 | 136,850,558 | 149,419,296 |
| Non-current assets | 62,230,102 | 82,303,499 | 117,236,017 | 130,493,870 | 138,480,858 | 137,408,544 | 140,788,645 | 152,484,335 |
| Current assets | 39,830,128 | 45,147,849 | 51,232,228 | 70,524,224 | 79,390,696 | 78,277,254 | 79,543,061 | 93,006,512 |
| Total assets | 102,060,230 | 127,451,348 | 168,468,245 | 201,018,094 | 217,871,554 | 215,685,798 | 220,331,706 | 245,490,847 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 991,522 | 959,480 | 915,033 |
| Social insurance contributions | - | - | - | - | - | 8,471,387 | 9,519,545 | 10,731,934 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.5% | +7.9% | +15.6% | -6.3% | +15.0% | +9.4% | +10.0% | +6.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.8% | 1.2% | 7.7% | 0.9% | 3.6% | 1.0% | -0.6% | 5.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.9% | 2.7% | 18.5% | 2.4% | 9.8% | 2.6% | -1.6% | 13.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.5% | 1.3% | 9.4% | 1.3% | 5.3% | 1.3% | -0.7% | 6.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.5% | 1.2% | 9.0% | 1.7% | 5.2% | 1.3% | -0.8% | 6.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 1.2 | 1.4 | 1.8 | 1.7 | 1.6 | 1.7 | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 46,816 | 51,399 | 55,776 | 52,706 | 63,196 | 72,505 | 76,855 | 79,056 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
INTERSURGICAL - Social security debts
The company had no debts to Sodra
INTERSURGICAL - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
INTERSURGICAL, UAB (code 111502432) is a Private Limited Liability Company engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year, 2025, the company generated revenue of €189.85M, up 6.1% year on year and 16.8% over two years. Net profit improved significantly to €12.55M in 2025 from a loss of €1.31M in 2024, after profit of €2.09M in 2023. This lifted the profit margin to 6.6%, compared with -0.7% in 2024 and 1.3% in 2023. The balance sheet expanded further in 2025, with total assets of €245.49M, equity of €93.04M and liabilities of €149.42M. Compared with 2024, assets, equity and liabilities all increased, indicating continued growth in scale. Key ratios show a solid operating base: return on equity was 13.5%, return on assets 5.1%, debt-to-equity 1.61, and asset turnover 0.77x. Revenue per employee was €79.1K, while profit per employee reached €5.2K, pointing to meaningful productivity at the latest reporting date.